Mid-term efficacy & safety of CDA vs ACDF for 1-level cervical disc spondylosis .
Effectiveness and safety of Mobi-C for treatment of single-level cervical disc spondylosis: a randomised control trial with a minimum of five years of follow-up
Bone Joint J. 2016 Jun;98-B(6):829-33107 patients with single-level cervical spondylosis were randomized to undergo either cervical disc arthroplasty (CDA) with the Mobi-C Cervical Disc Prosthesis or ACDF. The purpose of this study was to compare patient-reported outcome measures, the radiographic range of motion of the index segment, and subsequent surgery rates between groups. At 5 year follow-up, no significant differences were observed in patient-reported outcome measures. Subsequent surgery rates were significantly lower in the CDA group compared to the ACDF group, and range of motion of the index level was significantly higher in the CDA
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
